IL-6 Trans-Signaling Drives Murine Crescentic GN

Area of Science:

• Nephrology
• Immunology
• Molecular Biology

Background:

• The role of Interleukin-6 (IL-6) signaling in renal diseases is debated, with evidence for both pro- and anti-inflammatory effects.
• IL-6 exerts its functions through classic signaling (membrane-bound IL-6 receptor) and trans-signaling (soluble IL-6 receptor).

Purpose of the Study:

• To investigate the distinct roles of IL-6 classic signaling and trans-signaling in the pathogenesis of crescentic nephritis.
• To evaluate the therapeutic potential of targeting IL-6 trans-signaling in a mouse model of nephritis.

Main Methods:

• Analysis of IL-6 and soluble IL-6 receptor (sIL-6R) levels in human crescentic nephritis patients.
• Induction of nephrotoxic serum-induced nephritis (NTN) in BALB/c mice.
• Pharmacological inhibition of IL-6 classic signaling and trans-signaling pathways.
• Assessment of renal pathology, blood pressure, and gene expression (IL-17A, RELMalpha).

Main Results:

• Elevated IL-6 and sIL-6R levels were observed in patients and mice with crescentic nephritis.
• Specific inhibition of IL-6 trans-signaling ameliorated NTN severity, whereas broad IL-6 inhibition had no significant effect.
• Activation of IL-6 trans-signaling aggravated NTN, increased blood pressure, and altered renal gene expression towards pro-inflammatory Th17 responses.

Conclusions:

• IL-6 trans-signaling plays a critical, pro-inflammatory role in the development of crescentic nephritis.
• Targeting IL-6 trans-signaling specifically, rather than general IL-6 signaling, represents a promising therapeutic strategy for crescentic nephritis.